Literature DB >> 23116794

Influenza A(H1N1)pdm09: beyond the pandemic.

Diego Viasus1, Andrés Antón, Tomás Pumarola, Jordi Carratalà.   

Abstract

On August 2010, the World Health Organization declared the end to the 2009 A(H1N1) pandemic. However, influenza A(H1N1)pdm09 continues to circulate as a seasonal virus. Different viruses have predominated in different parts of the world. To date, influenza A(H1N1)pdm09 has demonstrated little antigenic drift, and its oseltamivir resistance has remained low. In some countries, a higher number of severe cases of influenza A(H1N1)pdm09 infection were documented during the 2010-2011 season than during the pandemic period. In addition, delays in oseltamivir administration, higher ages and comorbidities and low vaccination rates in patients with influenza A(H1N1)pdm09 infection were found during the first postpandemic season. Therefore, physicians should carefully consider the pandemic virus as a possible causative agent in patients with influenza-like illnesses admitted to emergency departments. In addition, surveillance systems and vaccination campaigns should continue after the pandemic period.
Copyright © 2012 Elsevier España, S.L. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23116794     DOI: 10.1016/S0213-005X(12)70106-4

Source DB:  PubMed          Journal:  Enferm Infecc Microbiol Clin        ISSN: 0213-005X            Impact factor:   1.731


  2 in total

1.  Return of pandemic H1N1 influenza virus.

Authors:  Hilda Sherbany; John McCauley; Tal Meningher; Musa Hindiyeh; Rita Dichtiar; Michal Perry Markovich; Ella Mendelson; Michal Mandelboim
Journal:  BMC Infect Dis       Date:  2014-12-31       Impact factor: 3.090

2.  Pathogenicity of pandemic H1N1 influenza A virus in immunocompromised cynomolgus macaques.

Authors:  Van Loi Pham; Misako Nakayama; Yasushi Itoh; Hirohito Ishigaki; Mitsutaka Kitano; Masahiko Arikata; Hideaki Ishida; Naoko Kitagawa; Shintaro Shichinohe; Masatoshi Okamatsu; Yoshihiro Sakoda; Hideaki Tsuchiya; Shinichiro Nakamura; Hiroshi Kida; Kazumasa Ogasawara
Journal:  PLoS One       Date:  2013-09-23       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.